KRT20 Antikörper (AA 196-323)

Produktnummer ABIN7871726

Dieser Maus Monoklonal Antikörper detektiert spezifisch KRT20 in IHC (p). Es zeigt Reaktivität gegenüber Proben von Human.

Kurzübersicht für KRT20 Antikörper (AA 196-323) (ABIN7871726)

Target: KRT20 (Keratin 20 (KRT20))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser KRT20 Antikörper ist unkonjugiert

Applikation: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Klon: KRT20-1993

Produktdetails anti-KRT20 Antikörper

Bindungsspezifität: AA 196-323

Verwendungszweck: CK20 Antibody / Cytokeratin 20 / KRT20

Aufreinigung: Protein G affinity chromatography

Immunogen: A portion of amino acids 196-323 from the human protein was used as the immunogen for this CK20 antibody.

Isotyp: IgG2b, kappa

Anwendungsinformationen

Applikationshinweise: Optimal dilution of the CK20 antibody should be determined by the researcher.

1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Prediluted in 1X PBS, 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide, *For IHC use only*

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store the CK20 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Details zu KRT20

Target: KRT20 (Keratin 20 (KRT20))

Andere Bezeichnung: CK20

Hintergrund: This mAb recognizes an intermediate filament protein of 46 kDa, identified as Cytokeratin 20 (KRT20, CK20). KRT is abundantly expressed in goblet cells and enterocytes of the gastrointestinal tract. It is a useful marker of pancreatic and colorectal cancer. KRT20 is expressed under normal, hyperplastic and neoplastic conditions. It has been detected in adenocarcinomas of the colon, stomach and biliary tract. Breast carcinomas are generally non-reactive.

UniProt: P35900